◆英語タイトル：Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis Review
Merrion Pharmaceuticals Plc (Merrion) is a product development company. It offers prescription pharmaceutical products to meet unmet needs in healthcare. The company focuses on the development of drugs in oral forms such as tablets and capsules that have limited absorption, and are generally given by injection. It has developed GIPET, a patented drug delivery technology that increases bioavailability, by enhancing absorption levels in the gastrointestinal tract. Merrion’s product portfolio includes Orazol, Almero, Acyline and MER-102. Its products find application in the treatment of diseases such as bone metastases, breast cancer, osteoporosis, prostate cancer and deep vein thrombosis. The company has agreements with several pharmaceutical companies; and through its license agreements with Novo Nordisk A/S develops and commercializes oral forms of Novo Nordisk’s Insulin and GLP-1, by utilizing the GIPET technology. Merrion is headquartered in Dublin, Ireland.
Merrion Pharmaceuticals Plc Key Recent Developments
Dec 23, 2013: Merrion Pharmaceuticals Announces Appointment of Director
Dec 23, 2013: Merrion Pharmaceuticals Announces Appointment of CEO and Chairman
Sep 30, 2013: Interim Results for the Six Months Ended 30 June 2013
Aug 20, 2013: Merrion Pharmaceuticals Announces Appointment of Non-Executive Director
This comprehensive SWOT profile of Merrion Pharmaceuticals Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Merrion Pharmaceuticals Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Merrion Pharmaceuticals Plc – Key Information
Merrion Pharmaceuticals Plc – Overview
Merrion Pharmaceuticals Plc – Key Employees
Merrion Pharmaceuticals Plc – Key Employee Biographies
Merrion Pharmaceuticals Plc – Key Operational Heads
Merrion Pharmaceuticals Plc – Major Products and Services
Merrion Pharmaceuticals Plc – History
Merrion Pharmaceuticals Plc – Company Statement
Merrion Pharmaceuticals Plc – Locations And Subsidiaries
Merrion Pharmaceuticals Plc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Merrion Pharmaceuticals Plc – Business Description
Merrion Pharmaceuticals Plc – Corporate Strategy
Merrion Pharmaceuticals Plc – SWOT Analysis
SWOT Analysis – Overview
Merrion Pharmaceuticals Plc – Strengths
Merrion Pharmaceuticals Plc – Weaknesses
Merrion Pharmaceuticals Plc – Opportunities
Merrion Pharmaceuticals Plc – Threats
Merrion Pharmaceuticals Plc – Key Competitors
Section 3 – Company Financial Performance Charts
Merrion Pharmaceuticals Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Merrion Pharmaceuticals Plc, Key Information
Merrion Pharmaceuticals Plc, Key Ratios
Merrion Pharmaceuticals Plc, Share Data
Merrion Pharmaceuticals Plc, Major Products and Services
Merrion Pharmaceuticals Plc, History
Merrion Pharmaceuticals Plc, Key Employees
Merrion Pharmaceuticals Plc, Key Employee Biographies
Merrion Pharmaceuticals Plc, Key Operational Heads
Merrion Pharmaceuticals Plc, Other Locations
Merrion Pharmaceuticals Plc, Subsidiaries
Merrion Pharmaceuticals Plc, Key Manufacturing facilities
Merrion Pharmaceuticals Plc, Key Competitors
Merrion Pharmaceuticals Plc, SWOT Analysis
Merrion Pharmaceuticals Plc, Ratios based on current share price
Merrion Pharmaceuticals Plc, Annual Ratios
Merrion Pharmaceuticals Plc, Interim Ratios
Capital Market Ratios
List of Figures
Merrion Pharmaceuticals Plc, Performance Chart
Merrion Pharmaceuticals Plc, Ratio Charts
| ★海外企業調査レポート[Merrion Pharmaceuticals Plc (3MP)：企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら